Cargando…
PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p/CDK4 axis
Drug resistance in tumors is a major issue, limiting the curative efficacy of currently available cancer chemotherapeutics. 5-Fluorouracil (5-FU) is a commonly applied therapeutic drug in colon cancer patient regimens; however, the majority of patients develop resistance to 5-FU in the later stages...
Autores principales: | Luo, Zhuhe, Chen, Ruijun, Hu, Shen, Huang, Xibin, Huang, Zhenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260730/ https://www.ncbi.nlm.nih.gov/pubmed/35814832 http://dx.doi.org/10.3892/ol.2022.13400 |
Ejemplares similares
-
The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4
por: Xing, Zhiwei, et al.
Publicado: (2020) -
Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
por: Shao, Yang, et al.
Publicado: (2016) -
circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD: Hpoxia induces circ-BPTF/miR-486-5p/CEMIP axis in COPD
por: Wang, Changguo, et al.
Publicado: (2022) -
miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022) -
Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma
por: Sun, Qiang, et al.
Publicado: (2021)